Nanobiotechnology boosts ferroptosis: opportunities and challenges

Area of Science:

• Biochemistry
• Biotechnology
• Oncology

Background:

• Ferroptosis is a distinct cell death pathway regulated by iron-dependent lipid peroxidation.
• Its regulation is closely linked to cellular metabolism, including iron, lipid, and redox pathways.
• Ferroptosis presents a promising strategy for overcoming cancer drug resistance.

Purpose of the Study:

• To systematically review the role of nanobiotechnology in enhancing ferroptosis-associated disease treatment.
• To explore the application of ferroptosis and nanobiotechnology beyond cancer, including neurodegenerative, cardiovascular, and kidney diseases.
• To analyze the clinical feasibility, limitations, and future directions of nanobiotechnology in ferroptosis.

Main Methods:

• Literature review of ferroptosis mechanisms and nanobiotechnology applications.
• Analysis of metabolic regulation in ferroptosis.
• Discussion of combined nanobiotechnology-ferroptosis strategies for therapeutic enhancement.

Main Results:

• Nanobiotechnology offers advantages in enhancing therapeutic efficacy and reducing side effects of ferroptosis-associated diseases.
• Ferroptosis has potential applications in various diseases beyond cancer.
• The integration of nanobiotechnology and ferroptosis requires further investigation for clinical translation.

Conclusions:

• Combining nanobiotechnology with ferroptosis holds significant potential for treating a range of diseases.
• Further research is needed to address limitations and accelerate clinical translation.
• This review provides guidance for future applications and clinical implementation of ferroptosis and nanobiotechnology.